Loading stock data…
NCNA
$1.96-0.01 (-0.48%)
Market OpenUpdated 12:30 PM EDT
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NuCana plc in the Healthcare sector is trading at $1.96 with a market capitalization of $8M. The stock is currently near its 52-week low of $1.33, remaining 35.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$4.78M↓ | -$2.84M↑ | -$3.57M↑ | -$11.63M↓ | -$2.79M |
| Net Income | -$3.87M↓ | -$2.48M↓ | -$281,000↑ | -$24.11M↓ | -$2.47M |
Peer Comparison
JNJUNHPFE
Fundamentals
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer in the United States. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs i...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.45M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
0.02
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.18
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-137.46%
Volume
Today's trading volume
13,691
Recent News
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week higher late M
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were declining late Wednesday mor
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
European equities traded in the US as American depositary receipts started the trading week lower la
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Flat for Week
European equities traded in the US as American depositary receipts were rising late Friday morning,
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were trending higher late Tuesday